NCT07377331 Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
| NCT ID | NCT07377331 |
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | Texas Christian University |
| Condition | Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 60 participants in total. It began in 2025-11-01 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching goal of this work is to determine methods that improve caregiver education about the behavioral and psychological symptoms (BPSD) of dementia. The specific goal of this project is to extend our prior work to evaluate the impact of our educational intervention on caregivers' ability to transfer knowledge about the management of ADRD to real-world applied examples.
Eligibility Criteria
Inclusion Criteria: * informal caregivers * 18+ years old * Read and speak English * free of cognitive impairments that prevent consent and/or completing experimental tasks * remote participants need access to a tablet, laptop, or desktop computer to complete tasks. Exclusion Criteria: * professional caregivers * former caregivers who are not currently caring for someone living with dementia * caregivers providing assistance to someone with normal cognition
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07377331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07377331 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07377331 currently recruiting?
Yes, NCT07377331 is actively recruiting participants. Contact the research team at memorylab@tcu.edu for enrollment information.
Where is the NCT07377331 trial being conducted?
This trial is being conducted at Fort Worth, United States, Norfolk, United States.
Who is sponsoring the NCT07377331 clinical trial?
NCT07377331 is sponsored by Texas Christian University. The trial plans to enroll 60 participants.